The company is pleased to confirm its projection of $5,000,000 net income from the product for its first year of production. All income will be recurring and is expected to grow substantially in succeeding years. http://www.findarticles.com/p/articles/mi_m0EIN/is_2002_June_6/ai_86827631 ===========
H-Quotient, Inc. (OTC Bulletin Board: HQNT) announced booking of more than 500 pre-production sales of LabQuotient, the company's innovative software system that matches diagnoses and tests for the medical, medical insurance, and medical legal communities.
President and CEO Douglas Cohn said, "The interest in LabQuotient is both gratifying and quite encouraging. These sales reinforce our first year projection of $5 million in net income from this superb product. Our enthusiasm and the market reception for LabQuotient continue unabated." http://www.findarticles.com/p/articles/mi_m0EIN/is_2002_July_12/ai_88820207 ==========
H-Quotient, Inc., Announces LabQuotient Contract for Canada Business Wire, July 29, 2002 President and CEO Douglas Cohn said, "This contract is an important step on our road to first year projected net income of $5 million or $.18 per share from LabQuotient. http://www.findarticles.com/p/articles/mi_m0EIN/is_2002_July_29/ai_89808243 ===========
H-Quotient, Inc.'s Initial LabQuotient Sales Top $300,000
H-Quotient, Inc., (OTCBB: HQNT) announced that initial sales of LabQuotient now exceed $300,000. LabQuotient is the company's innovative software system and database for medical and insurance professionals that links tests and diagnoses. Because LabQuotient is a subscription-based product, revenue is recurring.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.